Does Metformin Slow Aging? What the Evidence Shows

Metformin is cheap, generic, taken by millions, and has a decades-long safety record. It activates an enzyme called AMPK that cells use to sense low energy. In some model organisms it extends life. If you were going to nominate an existing drug as a candidate for slowing human aging, it is a reasonable first pick — and the field did exactly that.

What follows is not an argument that the idea is silly. It is an account of how much has actually been demonstrated in people, which is considerably less than the popular version suggests.

TAME — Targeting Aging with Metformin — is the study you will see referenced in almost every article on this subject. It was announced around 2015, designed to enrol roughly 3,000 people aged 65 to 79 and test whether metformin delays the accumulation of age-related disease.

As of July 2026, checked three independent ways:

• There is no ClinicalTrials.gov registration for TAME. Every "TAME" result in the registry is an unrelated trial.
• No NIH grant funds it. The NIH's own project database shows the lead investigator's funded work, and a TAME clinical trial award is not among it.
• The American Federation for Aging Research is still fundraising to launch it. Its own page files TAME under "Need — Raising Funds to Launch", and lists among what is still required: "Visionary donors", "3,000 individuals... to participate", and "An 'indication' for aging".

Nir Barzilai, the trial's lead investigator, put it plainly to STAT News in 2022: "I'm on the record saying I'm pretty sure it will start this year, for the last seven years. I have no credibility anymore. It's just incredibly frustrating. But it's going to happen, because it has to happen."

Speaking to NPR in 2024, he gave the reason: "The main obstacle with funding this study is that metformin is a generic drug, so no pharmaceutical company is standing to make money."

That is a real and depressing structural problem in medical research, and Barzilai is right to name it. But it does not change what a reader needs to know: TAME has enrolled nobody and reported nothing. If you encounter a page suggesting TAME is underway or has produced results — and several AI-generated pages ranking for this topic do — that is simply wrong.

AMPK: real, but probably not the point

Metformin does activate AMPK. That much is not in dispute.

The complication is a 2010 experiment in mice engineered to lack AMPK in the liver. Metformin lowered their blood glucose perfectly well anyway. The researchers described themselves as surprised. Whatever AMPK is doing, it is not required for the drug's signature effect.

The scientist who discovered AMPK co-authored a 2017 review concluding that metformin acts through both AMPK-dependent and AMPK-independent mechanisms, and that "more work is required to truly understand how this drug works in its target population."

So "it activates AMPK, therefore it slows aging" skips several steps that have not been established.

"Mimics caloric restriction" is a hypothesis

This phrase is used by researchers as an analogy — metformin produces some cellular signatures that resemble those of eating less. It is a reason to investigate, not a finding. It is regularly repeated as though it were settled, and it is not.

Human lifespan: no randomised evidence at all

This is the part that matters most and gets stated least. There is no randomised trial showing metformin extends human lifespan or healthspan. Not a small one, not a preliminary one. The question has not been answered because the study designed to answer it has not run.

Observational studies have suggested benefits, and one widely cited analysis reported that people with diabetes on metformin outlived people without diabetes. It did not survive closer examination — and it is vulnerable to exactly the immortal time bias that wrecked the metformin cancer literature.

Here is the finding that should give any enthusiast pause, and it is randomised, which most of this field's evidence is not.

The MASTERS trial put 94 healthy older adults through 14 weeks of supervised progressive resistance training, randomised to metformin or placebo. The placebo group gained more lean body mass and more thigh muscle mass. Scans confirmed greater increases in both muscle area and density on placebo. The authors' conclusion: "metformin negatively impacts the hypertrophic response to resistance training in healthy older individuals."

A companion analysis — co-authored by Nir Barzilai himself — confirmed it: "We found that metformin blunted PRT-induced muscle hypertrophic response." This is not a hostile result produced by sceptics outside the field.

A separate randomised trial found metformin inhibited mitochondrial adaptations to aerobic exercise training in older adults.

There is an irony worth sitting with. In MASTERS, metformin did increase AMPK signalling — the very mechanism the longevity case rests on — and that increase coincided with the blunted muscle gain.

Keeping muscle and fitness into later life is one of the few interventions with solid evidence behind it. A drug that measurably interferes with that, taken speculatively for an unproven benefit, is a trade worth understanding before you make it.

• Whether metformin extends human lifespan. No randomised data.
• Whether it protects against dementia. Genuinely unresolved.
• Whether people without diabetes benefit at all.

Not knowing is a legitimate answer, and it is the accurate one here.

Metformin is a prescription drug with a boxed warning about lactic acidosis, real contraindications including reduced kidney function, and a well-documented association with vitamin B12 deficiency over time. It is not a supplement, and taking it speculatively is a medical decision.

If you have type 2 diabetes and are prescribed metformin, none of this is an argument to stop. This page is about the second claim layered on top — that it slows aging — and how much of that has actually been shown.

Every figure above is from the trial publication or regulator named beside it, not from a summary of one. Where the honest answer is that nobody knows, this page says so rather than filling the gap.

Educational information, not medical advice. Do not start, stop or change any medication or supplement because of a web page — including this one. If you are on cancer treatment, tell your oncology team about everything you take, including supplements. Spotted an error? Please email [email protected] or use /corrections.